Both Ca2+-dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 2, 2007, Pages

  Laleman, Wim ^a   Van Landeghem, Lien ^a   Severi, Tamara ^a   Vander Elst, Ingrid ^a   Zeegers, Marcel ^a   Bisschops, Raf ^a   Van Pelt, Jos ^a   Roskams, Tania ^a   Cassiman, David ^a   Fevery, Johan ^a   Nevens, Frederik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Calcium calmodulin; Intrahepatic vascular resistance; Portal hypertension; Protein kinase C; RhoA; Stress relaxed matrix contraction

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIMYCIN; CALCIUM; CALYCULIN A; DIACETYL OXIME; METHOXAMINE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; STAUROSPORINE; THIOACETAMIDE; 2,3 BUTANEDIONE; AMIDE; DRUG DERIVATIVE; ENZYME INHIBITOR; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN KINASE; OXAZOLE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; SULFONAMIDE; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; LIVER CELL; LIVER CIRRHOSIS; MALE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; VASCULAR RESISTANCE; ANIMAL; CELL CULTURE; CELL SHAPE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HEART MUSCLE CELL; LIVER; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE FIBER; WISTAR RAT;

ACTOMYOSIN; AMIDES; ANIMALS; CALCIMYCIN; CALCIUM; CELL SHAPE; CELLS, CULTURED; DIACETYL; ENZYME INHIBITORS; LIVER; MALE; METHOXAMINE; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; MYOSIN-LIGHT-CHAIN KINASE; OXAZOLES; PROTEIN KINASE INHIBITORS; PYRIDINES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAUROSPORINE; SULFONAMIDES; VASOCONSTRICTOR AGENTS;

EID: 33847054334     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00196.2006     Document Type: Article

References (31)

1. Alpini G, Phillips JO, Vroman B, LaRusso NF. Recent advances in the isolation of liver cells. Hepatology 20: 494-514, 1994.
2. Bataller R, Gasull X, Gines P, Hellemans K, Gorbig MN, Nicolas JM, Sancho-Bru P, De Las Heras D, Gual A, Geerts A, Arroyo V, Rodes J. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33: 956-962, 2001.
3. Cassiman D, Denef C, Desmet VJ, Roskams T. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33: 148-158, 2001.
4. Cassiman D, Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J Hepatol 37: 527-535, 2002.
5. Friedmann SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835, 1993.
6. Graupera M, Garcia-Pagan JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, Rodes J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 37: 172-181, 2003.
7. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13: 264-269, 2003.
8. Harnett KM, Cao W, Biancani P. Signal-transduction pathways that regulate smooth muscle function. I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles. Am J Physiol Gastrointest Liver Physiol 288: G407-G416, 2005.
9. Janssens S, Flaherty D, Nong Z, Varenne O, van Pelt N, Haustermans C, Zoldhelyi P, Gerard R, Collen D. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97: 1274-1281, 1998.
10. Kawada N, Seki S, Kuroki T, Kaneda K. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun 266: 296-300, 1999.
11. Kolodney MS, Elson EL. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 268: 23850-23855, 1993.
12. Laleman W, Van Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int 25: 1079-1090, 2006.
13. Laleman W, Omasta A, Van de Casteele M, Zeegers M, Vander Elst I, Van Landeghem L, Severi T, van Pelt J, Roskams T, Fevery J, Nevens F. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Hepatology 42: 1382-1390, 2005.
14. Laleman W, Vander Elst I, Zeegers M, Servaes R, Libbrecht L, Roskams T, Fevery J, Nevens F. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. Eur J Clin Invest 36: 242-249, 2006.
15. i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol 290: G7-G13, 2006.
16. Nakagawa S, Pawelek P, Grinnell F. Extracellular matrix organization modulates fibroblast growth and growth factor responsiveness. Exp Cell Res 182: 572-582, 1989.
17. 2. Am J Physiol Cell Physiol 285: C1411-C1419, 2003.
18. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Torbenson M, Smedh U, Moran TH, Li Z, Huang J, Thomas SA, Diehl AM. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 53: 438-445, 2004.
19. Parizi M, Howard EW, Tomasek JJ. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 254: 210-220, 2000.
20. Petrov VV, Fagard RH, Lijnen PH. Arginine-aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover. Cardiovasc Res 61: 724-735, 2004.
21. Pfitzer G. Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 91: 497-503, 2001.
22. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, Giotti A, Gentilin P. Fat-storing cells as liver-specific pericytes: spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 90: 642-646, 1992.
23. Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50: 571-581, 2000.
24. Rockey DC. Vascular mediators in the injured liver. Hepatology 37: 4-12, 2003.
25. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 92: 1795-1804, 1993.
26. Saab S, Tam SP, Tran BN, Melton AC, Tangkijvanich P, Wong H, Yee HF Jr. Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1. J Biomed Sci 9: 607-612, 2002.
27. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000.
28. Taylor DA, Stull JT. Calcium dependence of myosin light chain phosphorylation in smooth muscle cells. J Biol Chem 263: 14456-14462, 1998.
29. van Bockxmeer FM, Martin CE, Constable IJ. Effect of cyclic AMP on cellular contractility and DNA synthesis in chorioretinal fibroblasts maintained in collagen matrices. Exp Cell Res 155: 413-421, 1984.
30. Yanase M, Ikeda H, Matsui A, Maekawa H, Noiri E, Tomiya T, Arai M, Yano T, Shibata M, Ikebe M, Fujiwara K, Rojkind M, Ogata I. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. Biochem Biophys Res Commun 277: 72-78, 2000.
31. Yanase M, Ikeda H, Ogata I, Matsui A, Noiri E, Tomiya T, Arai M, Inoue Y, Tejima K, Nagashima K, Nishikawa T, Shibata M, Ikebe M, Rojkind M, Fujiwara K. Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. Biochem Biophys Res Commun 305: 223-228, 2003.